Literature DB >> 17569103

Profiling the metabolic difference of seven tanshinones using high-performance liquid chromatography/multi-stage mass spectrometry with data-dependent acquisition.

Jianghao Sun1, Min Yang, Jian Han, Baorong Wang, Xiaochi Ma, Man Xu, Peng Liu, Dean Guo.   

Abstract

Tanshinones are a class of bioactive constituents in the roots of Salvia miltiorrhiza named Dan-Shen in Chinese, which possess diverse pharmacological activities. In this study, we employed a sensitive high-performance liquid chromatography/multi-stage mass spectrometry (HPLC/MS(n)) method with data-dependent acquisition and a dynamic exclusion program for the identification of phase I metabolites of seven tanshinones in rat bile after intravenous administration. These seven tanshinones are tanshinone IIA, sodium tanshinone IIA sulfonate (abbreviated as STS, a water-soluble derivate of tanshinone IIA), cryptotanshinone, 15,16-dihydrotanshinone I, tanshinone IIB, przewaquinone A and tanshinone I. Altogether 33 metabolites underwent monohydroxylation, dihydroxylation, dehydrogenation, D-ring hydrolysis or oxidation reactions in the C-4 or C-15 side chain which were characterized by analyzing the LC/MS(n) data. Different metabolic reactions for tanshinones were dependent on the degree of saturation and the substituent group in the skeleton. Dehydrogenation was the major metabolic modification for cryptotanshinone with saturated A and D rings. 15,16-Dihydrotanshinone I containing a saturated D ring was mainly metabolized through D-ring hydrolysis. For tanshinone IIA, possessing a saturated A ring, hydroxylation was the major metabolic pathway. When there was hydroxyl group substitution in the C-17 or C-18 position, such as przewaquinone A and tanshinone IIB, or sulfonic group substitution in the C-16 position, such as STS, higher metabolic stability than that of tanshinone IIA was shown and only trace metabolites were generated. Oxidation in the C-4 or C-15 side chain was a characteristic reaction for tanshinone IIA and hydroxylated tanshinone IIA. For tanshinone I, bearing unsaturated A and D rings simultaneously, no metabolites were detected. Copyright 2007 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17569103     DOI: 10.1002/rcm.3080

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  6 in total

1.  Data-dependent neutral gain MS3: toward automated identification of the N-oxide functional group in drug metabolites.

Authors:  Steven C Habicht; Nelson R Vinueza; Penggao Duan; Mingkun Fu; Hilkka I Kenttämaa
Journal:  J Am Soc Mass Spectrom       Date:  2010-01-07       Impact factor: 3.109

2.  Inhibition of the HIF-1 Survival Pathway as a Strategy to Augment Photodynamic Therapy Efficacy.

Authors:  Mark J de Keijzer; Daniel J de Klerk; Lianne R de Haan; Robert T van Kooten; Leonardo P Franchi; Lionel M Dias; Tony G Kleijn; Diederick J van Doorn; Michal Heger
Journal:  Methods Mol Biol       Date:  2022

3.  Charactering the metabolism of cryptotanshinone by human P450 enzymes and uridine diphosphate glucuronosyltransferases in vitro.

Authors:  Jin Zeng; Yu-Juan Fan; Bo Tan; Hui-Zong Su; Yue Li; Lin-Lin Zhang; Jian Jiang; Fu-Rong Qiu
Journal:  Acta Pharmacol Sin       Date:  2018-02-08       Impact factor: 6.150

4.  Metabolism of tanshinone IIA, cryptotanshinone and tanshinone I from Radix Salvia miltiorrhiza in zebrafish.

Authors:  Yingjie Wei; Ping Li; Changmei Wang; Yunru Peng; Luan Shu; Xiaobin Jia; Wenquan Ma; Bing Wang
Journal:  Molecules       Date:  2012-07-18       Impact factor: 4.411

Review 5.  Targeting Oxidative Stress and Endothelial Dysfunction Using Tanshinone IIA for the Treatment of Tissue Inflammation and Fibrosis.

Authors:  Tsuo-Cheng Lu; Yi-Hsiu Wu; Wei-Yu Chen; Yu-Chiang Hung
Journal:  Oxid Med Cell Longev       Date:  2022-04-07       Impact factor: 7.310

Review 6.  Molecular Mechanism of Tanshinone against Prostate Cancer.

Authors:  Wei Li; Tao Huang; Shenghan Xu; Bangwei Che; Ying Yu; Wenjun Zhang; Kaifa Tang
Journal:  Molecules       Date:  2022-08-30       Impact factor: 4.927

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.